Hill-Rom Hlds

Hill-Rom Holdings, Inc. operates as a medical technology company. The firm focuses on patient care solutions that improve clinical and economic outcomes. It operates through the following segments: Patient Support System, Front Line Care and Surgical Solutions. The Patient Support Systems segment provides bed frames and surfaces, mobility and clinical workflow solutions. The Front Line Care segment offers respiratory care products and sells medical diagnostic equipment and a diversified portfolio of devices. The Surgical Solutions segment supplies surgical products including tables, lights, pendants, positioning devices, various other surgical products and accessories. The company was founded by William A. Hillenbrand on August 7, 1969 and is headquartered in Chicago, IL.

Baxter completed its acquisition of Hill-Rom. If Baxter can execute on increasing the former Hill-Rom's sales footprint like I forecast as well as deliver on cost-cutting synergies, I estimate the stock to be worth $86.95.

I Am Bullish On Baxter Following Hill-Rom Acquisition

Alcoa

Baxter

NEW YORK, Dec. 13, 2021 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400: Alcoa Corp. (NYSE:AA) will replace Hill-Rom Holdings Inc. (NYSE:HRC) in the S&P MidCap 400 effective prior to the opening of trading on Monday, December 20. S&P 500 constituent Baxter International Inc. (NYSE: BAX) is acquiring Hill-Rom in a deal that was completed today.

Alcoa Set to Join S&P MidCap 400

Abbott Labs

Bio-Rad Laboratories

Despite the COVID-19 pandemic induced challenges, rising demand for IVD coupled with dependence on AI & Robotics should lend support to the Zacks Medical-Products industry. ABT, BIO and HRC are well-poised to gain from the prospects.

3 Stocks to Capitalize on the Buoyant Medical Products Industry

CHICAGO, Dec. 2, 2021 /PRNewswire/ -- Hillrom (NYSE: HRC) today announced that its shareholders have voted to approve the previously announced pending acquisition by Baxter International Inc. (NYCE: BAX) at a special meeting. Hillrom shareholders voted overwhelmingly in favor of the transaction.

Hillrom Shareholders Approve Acquisition By Baxter

Investors are optimistic about Hill-Rom (HRC) on strong fiscal fourth-quarter results and progress in digital health.

Here's Why You Should Add Hill-Rom (HRC) to Your Portfolio

Strong underlying performance and continued recovery across all three business segments drove Hill-Rom's (HRC) fourth-quarter fiscal 2021 revenues.

Hill-Rom (HRC) Q4 Earnings Surpass Estimates, Margins Up

CHICAGO, Nov. 5, 2021 /PRNewswire/ -- Hillrom (NYSE: HRC) today announced financial results for its fiscal fourth quarter and full-year ended September 30, 2021. For the fiscal fourth quarter, Hillrom reported GAAP earnings of $0.80 per diluted share, an increase of 27 percent compared to $0.63 per diluted share in the prior-year period.

Hillrom Exceeds Fourth Quarter Guidance With Strong Finish To Fiscal Year

CHICAGO, Nov. 2, 2021 /PRNewswire/ -- Hillrom (NYSE: HRC) announced today that its board of directors declared a quarterly dividend of $0.24 per share payable on December 31, 2021, to shareholders of record as of the close of business on December 15, 2021. The indicated annual dividend rate is $0.96 per share.

Hillrom Declares Quarterly Dividend

Hill-Rom (HRC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Hill-Rom (HRC) Earnings Expected to Grow: What to Know Ahead of Q4 Release

Investors are optimistic about Hill-Rom (HRC) owing to strategic buyouts and continued expansion efforts in the digital health space.

Here's Why You Should Hold on to Hill-Rom (HRC) for Now

Atlas Air Worldwide

Ashland Global Hlds

Athene Holding Ltd. Class A

Celsius Holdings

Capri Holdings Ltd

Camping World Hlds

When you're looking for stocks to buy that you can hold for years to come, what's in a name is sometimes all you need to find your way. The post 7 Stocks to Buy That Investors Should Keep ‘Holding' for Years to Come appeared first on InvestorPlace.

7 Stocks to Buy That Investors Should Keep ‘Holding' for Years to Come

Hill-Rom's (HRC) newly initiated long-term growth strategies through fiscal 2022, focusing on all four strategic priorities, look attractive at this moment.

Hill-Rom (HRC) New LT Strategy Aids, Y/Y Comparisons Ail

Boston Scientific

Catalent

Medtronic

Intersect ENT

MedTech stocks like Boston Scientific (BSX), Catalent (CTLT) and Baxter (BAX) are likely to solidify businesses on the back of impressive M&As.

MedTech Thrives on M&A Frenzy: 3 Stocks to Focus on

First Interstate BancSystem

Triple-S Management

JMP Group

Kadmon Hlds

NEW YORK, Sept. 20, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Triple-S Management Corporation (NYSE: GTS)  concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to GuideWell Mutual Holding Corporation for $36.00 per share in cash.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates GTS, HRC, JMP, KDMN, FIBK; Shareholders are Encouraged to Contact the Firm

Diversicare Healthcare Services

Echo Global Logistics

NEW YORK, Sept. 17, 2021 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: Joshua Rubin, Esq.

SHAREHOLDER ALERT: WeissLaw LLP Reminds ECHO, KDMN, HRC, and DVCR Shareholders About Its Ongoing Investigations

Last month we discussed that the stock price of Hill-Rom Holdings, best known for its hospital beds and patient mobility solutions, will likely see further gains if Baxter were to revise its acquisition bid. Baxter has now revised its offer from $144 per share to $156 per share for Hill-Rom

Hill-Rom Stock Rises After Baxter's Revised Bid

NEW YORK, Sept. 11, 2021 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating Hill-Rom Holdings, Inc. ("HRC" or the "Company") (HRC) relating to its proposed acquisition by Baxter International, Inc. Under the terms of the agreement, HRC shareholders will receive $156.00 in cash per share they own.

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Hill-Rom Holdings, Inc. - HRC

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Hill-Rom Holdings, Inc. (NYSE: HRC) to Baxter International Inc. (NYSE: BAX). Under the terms of the proposed transaction, shareholders of Hill-Rom will receive only $156.00 in cash for each share of Hill-Rom that they own. KSF is seeking to determine whether this consideration and the process that led to it a

HILL-ROM HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Hill-Rom Holdings, Inc. - HRC

Baxter's (BAX) latest acquisition is likely to accelerate its digitally-enabled connected care solutions across the care continuum and enhance patient services.

Baxter (BAX) to Benefit From Hill-Rom Buyout: Here's How

NEW YORK, Sept. 3, 2021 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Hill-Rom Holdings, Inc. ("Hill-Rom" or the "Company") (NYSE: HRC) in connection with the proposed acquisition of the Company by Baxter International Inc.("Baxter") (NYSE: BAX).

SHAREHOLDER ALERT: WeissLaw LLP Investigates Hill-Rom Holdings, Inc.

The transaction is expected to close by early 2022 subject to the approval of Hill-Rom (HRC) shareholders and the fulfillment of customary closing conditions.

Hill-Rom (HRC) Agrees to Get Acquired by Baxter, Shares Jump

Hill-Rom (HRC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Hill-Rom (HRC) Hits 52-Week High, Can the Run Continue?

MILWAUKEE, Sept. 3, 2021 /PRNewswire/ -- Ademi LLP is investigating Hill-Rom (NYSE: HRC), for possible breaches of fiduciary duty and other violations of law in its transaction with Baxter.

Shareholder Alert: Ademi LLP investigates whether Hill-Rom Holdings, Inc. has obtained a Fair Price in its transaction with Baxter

NEW YORK, Sept. 2, 2021 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Hill-Rom Holdings, Inc. (NYSE: HRC) and its board of directors concerning the proposed acquisition of the company by Baxter International Inc. (NYSE: BAX).

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Hill-Rom Holdings, Inc.

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Hill-Rom Holdings, Inc. (NYSE: HRC) to Baxter International Inc. for $156.00 per share in cash is fair to Hill-Rom shareholders. Halper Sadeh encourages Hill-Rom shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concerns wh

Hill-Rom Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Hill-Rom Holdings, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – HRC

News for Hill-Rom Hlds Stock (HRC)